Christine Canning

5.2k total citations · 2 hit papers
43 papers, 4.0k citations indexed

About

Christine Canning is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Christine Canning has authored 43 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 28 papers in Hematology and 11 papers in Oncology. Recurrent topics in Christine Canning's work include Hematopoietic Stem Cell Transplantation (22 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Christine Canning is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Christine Canning collaborates with scholars based in United States, Germany and Australia. Christine Canning's co-authors include Jerome Ritz, Robert J. Soiffer, Edwin P. Alyea, Donna Neuberg, Catherine J. Wu, Roberto Bellucci, Emmanuel Zorn, Glenn Dranoff, Robert Schlossman and Haesook Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christine Canning

43 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

2006 601 citations Emmanuel Zorn, Haesook Kim et al. Blood profile →
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

2008 488 citations F. Stephen Hodi, Marcus O. Butler et al. Proceedings of the National Academy of Sciences profile →

Peers

Christine Canning

IMMUN

ONCOL

HEMAT

RHEUM

Bertrand Huard Switzerland

Jochen Greiner Germany

Johanna Olweus Norway

Agnes S. M. Yong Australia

Lewis C. Strauss United States

Erik A. Ranheim United States

Edward D. Ball United States

Keyvan Keyvanfar United States

J C Brouet France

John Daley United States

Bertrand Huard Switzerland

Christine Canning

3.3k ×1.2

IMMUN

1.7k ×1.0

ONCOL

534 ×0.4

HEMAT

630 ×1.1

395 ×1.3

RHEUM

Citations per year, relative to Christine Canning Christine Canning (= 1×) peers Bertrand Huard

Countries citing papers authored by Christine Canning

Since Specialization

Citations

This map shows the geographic impact of Christine Canning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Canning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Canning more than expected).

Fields of papers citing papers by Christine Canning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Canning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Canning. The network helps show where Christine Canning may publish in the future.

Co-authorship network of co-authors of Christine Canning

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Canning. A scholar is included among the top collaborators of Christine Canning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Canning. Christine Canning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Exley, Mark A., Phillip Friedlander, Nadia Alatrakchi, et al.. (2017). Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial. Clinical Cancer Research. 23(14). 3510–3519. 126 indexed citations

Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations

Bachireddy, Pavan, Ursula Hainz, Michael S. Rooney, et al.. (2013). Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood. 123(9). 1412–1421. 73 indexed citations

Hainz, Ursula, Martha Wadleigh, Donna Neuberg, et al.. (2012). Detecting T-cell reactivity to whole cell vaccines. OncoImmunology. 1(7). 1095–1103. 14 indexed citations

Biernacki, Melinda A., Ovidiu Marina, Wandi Zhang, et al.. (2010). Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells. Cancer Research. 70(3). 906–915. 43 indexed citations

Marina, Ovidiu, Ursula Hainz, Melinda A. Biernacki, et al.. (2010). Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens. Cancer Research. 70(4). 1344–1355. 28 indexed citations

Zhang, Wandi, Wanyong Zeng, Shelby A. Rogers, et al.. (2010). Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion. Clinical Cancer Research. 16(10). 2729–2739. 30 indexed citations

Stone, Richard M., Daniel J. DeAngelo, Ilene Galinsky, et al.. (2008). Low dose interleukin‐2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission. American Journal of Hematology. 83(10). 771–777. 16 indexed citations

Hodi, F. Stephen, Marcus O. Butler, Darryl A. Oble, et al.. (2008). Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proceedings of the National Academy of Sciences. 105(8). 3005–3010. 488 indexed citations breakdown →

10.

Solomon, David H., Nicola Goodson, J.N. Katz, et al.. (2006). Patterns of cardiovascular risk in rheumatoid arthritis. Annals of the Rheumatic Diseases. 65(12). 1608–1612. 331 indexed citations

11.

Alyea, Edwin P., Edie Weller, RL Schlossman, et al.. (2003). Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Bone Marrow Transplantation. 32(12). 1145–1151. 53 indexed citations

12.

Friedberg, Jonathan W., Donna Neuberg, John G. Gribben, et al.. (2002). Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non‐Hodgkin's lymphoma. British Journal of Haematology. 117(4). 828–834. 109 indexed citations

13.

Yang, Xiaofeng, Catherine J. Wu, Lingyun Chen, et al.. (2002). CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.. PubMed. 62(19). 5517–5522. 75 indexed citations

14.

Zorn, Emmanuel, Enrica Orsini, Catherine J. Wu, et al.. (2001). A CD4+ T CELL CLONE SELECTED FROM A CML PATIENT AFTER DONOR LYMPHOCYTE INFUSION RECOGNIZES BCR-ABL BREAKPOINT PEPTIDES BUT NOT TUMOR CELLS1. Transplantation. 71(8). 1131–1137. 19 indexed citations

15.

Orsini, Enrica, Edwin P. Alyea, Antoinette Chillemi, et al.. (2000). Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma. Biology of Blood and Marrow Transplantation. 6(4). 375–386. 59 indexed citations

16.

Orsini, Enrica, R Schlossman, Christine Canning, et al.. (2000). Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplantation. 25(6). 623–632. 58 indexed citations

17.

Wu, Catherine J., Xiaofeng Yang, Stephen McLaughlin, et al.. (2000). Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. Journal of Clinical Investigation. 106(5). 705–714. 111 indexed citations

18.

Alyea, Edwin P., Robert J. Soiffer, Christine Canning, et al.. (1998). Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant. Blood. 91(10). 3671–3680. 19 indexed citations

19.

Taplin, Mary‐Ellen, et al.. (1996). Evidence against T‐cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression. Immunology. 87(3). 402–407. 11 indexed citations

20.

Canning, Christine. (1991). What Teachers Say about Reflection.. Educational leadership. 48(6). 18–21. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact